Results 161 to 170 of about 60,195 (236)

The changing landscape of urothelial carcinoma: on the edge of a paradigm shift. [PDF]

J Clin Invest
Meeks JJ.
europepmc   +1 more source

Integrated Genomic and Single-Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma. [PDF]

Hum Mutat
Tang C, Liu Y, Wang TL, Ma J, Chen W, Liu X, Xue J, Ye L, Yue F.   +8 more
europepmc   +1 more source

Multiplexed Immunofluorescent Characterization of T‐Cell and Myeloid Cell Populations Reveals Histologic Subtype Differences Within the Immunosuppressive Landscape of Human Basal Cell Carcinoma

Journal of Cutaneous Pathology, Volume 53, Issue 7, Page 624-632, July 2026.
ABSTRACT Background Basal cell carcinomas (BCCs) are thought to reside within an immunosuppressed tumor microenvironment, but a detailed characterization of BCC‐associated immune cells was lacking. Methods Utilizing multiplex immunohistochemistry (IHC) (Vectra Polaris, Akoya Biosciences), we designed two staining panels, targeting either T cells (CD3 ...
Alan S. Shen, Lauren E. Heusinkveld, Ajay Zalavadia, Andrelie Branicky, Sanjay Anand, Melissa Piliang, Edward V. Maytin   +6 more
wiley   +1 more source

Circulating Tumor DNA in Upper Tract Urothelial Carcinoma: A Framework for Precision Perioperative Management. [PDF]

Cancers (Basel)
Prakash A, Cherico A, Ayanambakkam A, Polimera HV.   +3 more
europepmc   +1 more source

Design and Synthesis of Pyrimidino[4,5‐d]Pyrimidine‐Based Compounds as Potent B‐RAF V600E Inhibitors

ChemMedChem, Volume 21, Issue 11, 15 June 2026.
Novel pyrimido[4,5‐d]pyrimidine‐based inhibitors selectively target B‐RAF V600E with nanomolar affinity and adopt distinct type‐II binding modes. Complementary cellular profiling reveals highly active analogs, underscoring the versatility of this chemotype and establishing it as a promising scaffold for the development of next‐generation kinase ...
Eleftheria A. Georgiou, Kalliopi Christopoulou, Amalia D. Kalampaliki, Aikaterini F. Giannopoulou, Eleftheria Chatziorfanou, Vivi Bafiti, Andreas Krämer, Athanasios Papakyriakou, Dimitrios J. Stravopodis, Stefan Knapp, Ioannis K. Kostakis   +10 more
wiley   +1 more source

HER2/neu and Ki-67 as prognostic biomarkers in urothelial carcinoma. [PDF]

Bioinformation
Rawat A, Joshi H, Mitra N, Bhardwaj R.
europepmc   +1 more source

Immunohistochemistry-based risk stratification of upper tract urothelial carcinoma. [PDF]

Front Oncol
He DL, Zi GR, Zhang DJ, Zhong HQ, Wang C, Feng RL, Ke CX.   +6 more
europepmc   +1 more source

Editorial Comment on Rapid Systemic Progression After Ureteroscopic Holmium:YAG Laser Ablation for High‐Grade Upper Tract Urothelial Carcinoma in a Solitary Kidney: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
Takahiro Kojima
wiley   +1 more source

Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma. [PDF]

J Immunother Cancer
Ding Y, Jin K, Su X, Zhang L, Liu Z, Sun J, Wu Y, Shi J, Zeng H, Liu H, Zhu Y, Xu L, Wang Z, Chang Y, Zhang W, Xu J, Shanghai Urothelial Carcinoma Research Group (SUCRG).   +16 more
europepmc   +1 more source